These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7098372)

  • 1. [Partial lipodystrophy with osteomyelitis (author's transl)].
    Böhles H; Kövary PM
    Klin Padiatr; 1982 Mar; 194(2):124-7. PubMed ID: 7098372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Partial lipodystrophy with osteomyelitis].
    Böhles H; Kövary PM
    Z Hautkr; 1982 Jan; 57(2):91-100. PubMed ID: 7072309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP; Kourilsky O; Morel-Maroger L; Adam C
    N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Partial lipodystrophy (cephalothoracic type) with asymptomatic dense deposit disease (author's transl)].
    Houssin A; Saint-André JP; Buzelin F; Guenel J
    Ann Med Interne (Paris); 1981; 132(1):44-7. PubMed ID: 7224470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of C3 nephritic factor on the complement system--with special reference to stabilizing effect on C3 convertase (C3bBb) activity (author's transl)].
    Nakanishi I
    Nihon Jinzo Gakkai Shi; 1981 Jun; 23(6):719-32. PubMed ID: 6914399
    [No Abstract]   [Full Text] [Related]  

  • 7. [Partial lipodystrophy and membranoproliferative glomerulonephritis. Apropos of a case].
    Martínez Debora MJ; Vázquez Martul M; Ecija Peiró JL; González Pérez J; Lirio Rodríguez J; González Mediero I
    An Esp Pediatr; 1989 Jun; 30(6):499-502. PubMed ID: 2679278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus, C3 nephritic factor and partial lipodystrophy.
    Cronin CC; Higgins TJ; Molloy M
    QJM; 1995 Apr; 88(4):298-9. PubMed ID: 7796081
    [No Abstract]   [Full Text] [Related]  

  • 9. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of partial lipoatrophy and C3 hypocomplementaemia: a report of two cases.
    Wayte J; Bird G; Wilkinson JD
    Clin Exp Dermatol; 1996 Mar; 21(2):131-4. PubMed ID: 8759201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
    Yamada A; Ohi H; Okano K; Watanabe S; Seki M; Hatano M; Koitabashi Y
    J Clin Lab Immunol; 1988 Sep; 27(1):35-7. PubMed ID: 3251045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
    Power DA; Ng YC; Simpson JG
    Q J Med; 1990 Apr; 75(276):387-98. PubMed ID: 2385743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Partial lipodystrophy].
    Ann Dermatol Venereol; 1980; 107(12):1231-4. PubMed ID: 7015973
    [No Abstract]   [Full Text] [Related]  

  • 14. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.
    Bennett WM; Bardana EJ; Wuepper K; Houghton D; Border WA; Götze O; Schreiber R
    Am J Med; 1977 May; 62(5):757-60. PubMed ID: 860726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 nephritic factor in an individual with recurrent viral infection and lipodystrophy.
    Myers B; Chambers R; Anderson A; Barry R; Wallington T; Whicher J
    J Clin Lab Immunol; 1986 Apr; 19(4):201-4. PubMed ID: 3723590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Barraquer and Simons lipodystrophy. Complement anomalies and cutaneous leukocytoclasic vasculitis].
    Perrot H; Delaup JP; Chouvet B
    Ann Dermatol Venereol; 1987; 114(9):1083-91. PubMed ID: 3434945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
    Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3 nephritic factor and SLE: report of four cases and review of the literature.
    Walport MJ; Davies KA; Botto M; Naughton MA; Isenberg DA; Biasi D; Powell RJ; Cheung NT; Struthers GR
    QJM; 1994 Oct; 87(10):609-15. PubMed ID: 7987656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M; Sich M; Habib R
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Partial lipodystrophy: a spot diagnosis].
    Fidder AR; van der Deure H; Westra DW
    Ned Tijdschr Geneeskd; 2015; 159():A8872. PubMed ID: 26374720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.